RBR-62qgf6Completed未知
Contraception in women with Sicle Cell Disease: a cohort study
Instituto de Medicina Integral Prof. Fernando Figueira0 sitesStarted: March 15, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 15Y to 40Y (—)
- Sex
- Female
Inclusion Criteria
- •Women with Sicle Cell Disease; Age between fifteen and forty years; Woman with sexual activity; Desire for contraception
Exclusion Criteria
- •Women with difficulty understanding the questions included in the questionnaire at the initial moment of the research; Women who have the HbSC genotype; Women using prophylactic continuous blood transfusion
Investigators
Similar Trials
Completed
Not Applicable
HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell PatientsSickle Cell Disease and PregnancyNCT06620887Hospices Civils de Lyon100
Not yet recruiting
Phase 4
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
Completed
Phase 3
Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)PreeclampsiaPregnancy ComplicationsSickle Cell DiseaseIntrauterine Growth RestrictionNCT05253781University of Lagos, Nigeria476
Completed
Phase 4
Contraception in Women With Sickle Cell DiseaseSickle Cell DiseaseNCT02594462University of Sao Paulo29
Active, not recruiting
Not Applicable
Sickle Cell Disease Obstetric Multi-Disciplinary Care ProgrammePregnancy RelatedSickle Cell DiseaseNCT05143021Vanderbilt University Medical Center500